The Biotech Growth Trust PLC (BIOG) — Cash Flow-to-Debt Ratio
The Biotech Growth Trust PLC (BIOG) has a Cash Flow-to-Debt Ratio of -0.08x as of September 2025, meaning its operating cash flow of GBX-2.52 Million could theoretically repay 0% of its total liabilities (GBX32.10 Million) in one year. See BIOG FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
The Biotech Growth Trust PLC Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for The Biotech Growth Trust PLC across 14 annual periods. For the full cash flow conversion analysis, see BIOG cash flow conversion.
Annual Cash Flow-to-Debt Ratio for The Biotech Growth Trust PLC (2012–2025)
Year-by-year debt coverage analysis for The Biotech Growth Trust PLC. Check BIOG cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.94x | GBX-5.09 Million | GBX5.42 Million | ▼ -1008.4% |
| 2024 | -0.08x | GBX-4.24 Million | GBX50.11 Million | ▲ +56.6% |
| 2023 | -0.19x | GBX-5.89 Million | GBX30.22 Million | ▲ +46.6% |
| 2022 | -0.37x | GBX-12.14 Million | GBX33.24 Million | ▼ -209.4% |
| 2021 | -0.12x | GBX-5.67 Million | GBX48.06 Million | ▼ -11.7% |
| 2020 | -0.11x | GBX-3.77 Million | GBX35.62 Million | ▲ +46.3% |
| 2019 | -0.20x | GBX-4.40 Million | GBX22.36 Million | ▼ -37.5% |
| 2018 | -0.14x | GBX-4.11 Million | GBX28.68 Million | ▲ +64.6% |
| 2017 | -0.40x | GBX-5.29 Million | GBX13.08 Million | ▼ -218.5% |
| 2016 | -0.13x | GBX-5.91 Million | GBX46.58 Million | ▼ -1060.3% |
| 2015 | 0.01x | GBX703.00K | GBX53.23 Million | ▲ +101.0% |
| 2014 | -1.30x | GBX-52.25 Million | GBX40.19 Million | ▼ -2603.2% |
| 2013 | 0.05x | GBX1.15 Million | GBX22.22 Million | ▲ +167.9% |
| 2012 | -0.08x | GBX-439.00K | GBX5.74 Million | — |